Jaguar Health Stock Plan Amendment
Jaguar Health filed a proxy supplement regarding Proposal 3 for its upcoming special meeting, seeking shareholder approval to increase the 2014 Stock Incentive Plan's authorized shares to 378,859. This share reserve represents 14% of the company's issued and outstanding common stock on a fully diluted basis as of September 30, 2026. The supplement clarifies the share count following a special one-time dividend of Series R Preferred Stock and its subsequent conversion into common stock.